LapLav: A National Study of Clinical Results After Emergency Operation for Perforated Diverticulitis

Sponsor
Sahlgrenska University Hospital, Sweden (Other)
Overall Status
Enrolling by invitation
CT.gov ID
NCT03332550
Collaborator
(none)
1,000
1
55.5
18

Study Details

Study Description

Brief Summary

The aim of this study is to evaluate clinical results and effect on health and well-being in patients operated for perforated diverticulitis with purulent peritonitis by laparoscopic lavage in Sweden when used outside of prospective studies/trials and in comparison with the traditional treatment, i.e. colon resection with or without stoma formation.

A secondary aim is to evaluate the outcome after fecal peritonitis.

The hypothesis is that laparoscopic lavage as treatment for perforated diverticulitis with purulent peritonitis is safe, efficient and cost saving, when used in routine health care.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Laparoscopic lavage
  • Procedure: Colon resection

Study Design

Study Type:
Observational
Anticipated Enrollment :
1000 participants
Observational Model:
Cohort
Time Perspective:
Retrospective
Official Title:
A National, Registry Based Study of Clinical Results After Emergency Operation for Perforated Diverticulitis to Compare Laparoscopic Lavage and Resection Surgery in Routine Use.
Actual Study Start Date :
Apr 18, 2018
Actual Primary Completion Date :
Dec 31, 2020
Anticipated Study Completion Date :
Dec 1, 2022

Arms and Interventions

Arm Intervention/Treatment
purulent peritonitis

Hinchey 3

Procedure: Laparoscopic lavage
Operation with laparoscopic lavage for perforated diverticulitis Hinchey 3

Procedure: Colon resection
Operation with colon resection for perforated diverticulitis Hinchey 4

faecal peritonitis

Hinchey 4

Procedure: Colon resection
Operation with colon resection for perforated diverticulitis Hinchey 4

Outcome Measures

Primary Outcome Measures

  1. Need for further surgical interventions within 12 months of index surgery [12 months]

    Number of patients in need of further surgical interventions within 12 months after index surgery.

Secondary Outcome Measures

  1. Need for further surgical interventions within 24 months of index surgery [24 months]

    Number of patients in need of further surgical interventions within 24 months after index surgery.

  2. Colon cancer diagnosis [12 months]

    Number of colon cancer diagnosis within 12 months

  3. Health economics with regard to the two different treatment modalities. [2 years]

    In the analysis data from the study will be combined with prices from the cost-per-patient system at Sveriges Kommuner och Landsting, or where appropriate, from Sahlgrenska University Hospital, in combination with sensitivity testing of results.

  4. Percentages of all cases treated by laparoscopic lavage and emergency colon resection, respectively. [36 months]

    Percentages of all cases treated by laparoscopic lavage and emergency colon resection, respectively in a national Swedish cohort and in routine health care.

  5. Complications (Clavien-Dindo ≥ IIIa) within 90 days of index surgery. [90 days]

    Complications (Clavien-Dindo ≥ IIIa) within 90 days of index surgery.

  6. Mortality (90 days and 12 months respectively). [12 months]

    Mortality (90 days and 12 months respectively).

  7. Patient reported outcome after treatment for perforated diverticulitis, function [3 years]

    Patient reported outcome as measured using a disease specific questionnaire 2-3 years after index surgery. The questionnaire is developed specifically for this study and will address prevalence, severity and associated distress of symptoms using Likert-type scales regarding function after surgery for perforated diverticulitis.

  8. Patient reported outcome after treatment for perforated diverticulitis, quality of life [3 years]

    Patient reported outcome using a questionnaire sent out 2-3 years after index surgery for perforated diverticulitis, using EQ-5D for quality of life.

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • All patients registered in the Patient registry with ICD 10 codes K57 classified as emergency admissions and with the Nordic Medico-Statistical Committee (NOMESCO) code JAH01(diagnostic laparoscopy), JFB46 (resection of sigmoid colon), JFB60 (resection of sigmoid colon, sigmoidostomy and closure of the distal stump), JFB61 (laparoscopic resection of sigmoid colon, sigmoidostomy and closure of the distal stump), JFB63 (other colon resection, colostomy and closure of the distal stump), JAK04 (laparoscopy and peritoneal lavage), JAW97 (other laparoscopic operation involving abdominal wall, mesentery, peritoneum or the omentum)
Exclusion Criteria:
  • Patients where hospital records reveal that the index admission was misclassified (not perforated diverticulitis) will be excluded.

  • Patients classified as Hinchey 1-2.

  • No informed consent received or withdrawal of consent (questionnaire)

Contacts and Locations

Locations

Site City State Country Postal Code
1 Sahlgrenska University Hospital Gothenburg Västa Götaland Sweden 413 45

Sponsors and Collaborators

  • Sahlgrenska University Hospital, Sweden

Investigators

  • Principal Investigator: Eva Haglind, Sahlgrenska University Hospital, Sweden

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Eva Haglind, MD, PhD, professor, MD, PhD, professor, Sahlgrenska University Hospital, Sweden
ClinicalTrials.gov Identifier:
NCT03332550
Other Study ID Numbers:
  • LapLav
First Posted:
Nov 6, 2017
Last Update Posted:
Mar 19, 2021
Last Verified:
Mar 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Eva Haglind, MD, PhD, professor, MD, PhD, professor, Sahlgrenska University Hospital, Sweden
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 19, 2021